Topics:

Arthritis

Joint Focus: Spondyloarthritis

For the first time, two societies devoted to spondyloarthropathies have met in joint session. Rheumatology Network was on site to learn the latest from the SPARTAN-GRAPPA conference:
-- Progress toward new PsA criteria ,
-- Impending North American guidelines on spondyloarthropathies, and
-- The growing voice of PsA patients in defining outcomes.

Arthritis

Tumor necrosis factor blockers have a comparatively low infection risk and appear to slow progression in patients with ankylosing spondylitis

The FDA has approved a smaller-particle NSAID formulation that relieves osteoarthritis pain with few adverse effects.

Is methotrexate a good option for knee osteoarthritis? A commentary finds that the study supporting the idea provides good evidence in its favor.

A new auto-injectable form of methotrexate offers 10 dosage options. Is this an important advantage for medication management and adherence over the four already available?

An IL4 fusion protein has completely resolved rheumatoid arthritis in a mouse study using a standard collagen-induced model of the disease.

Knee osteoarthritis can trigger a series of clinical problems that set patients on the road to early frailty, especially if both knees are involved. It's prudent for their physicians to be on high alert for it.

About half of rheumatoid arthritis patients don't understand enough information to make intelligent treatment choices. Here's how to help.

Pages

Subscribe to Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.